The evolution of cardiac changes after breast cancer adjuvant radiotherapy – A six-year follow-up study
Subclinical deterioration in cardiac function and elevated biomarkers were evident three years after RT and persisted at six years, suggesting permanent cardiac effects. Both radiation dose and AI therapy contributed to these changes. These findings underscore the importance of long-term cardiac monitoring and support the use of sensitive imaging and biomarkers to detect early radiotherapy-induced cardiotoxicity.
Authors
- Mikko Moisander (ORCID: https://orcid.org/0000-0002-6935-9893)
- Kjell Nikus (ORCID: https://orcid.org/0000-0002-9345-9851)
- Tanja Skyttä (ORCID: https://orcid.org/0000-0003-0024-442X)
- Vesa Virtanen (ORCID: https://orcid.org/0000-0002-5797-5365)
- Pekka Raatikainen (ORCID: https://orcid.org/0000-0002-3502-8789)
- Heini Huhtala (ORCID: https://orcid.org/0000-0003-1372-430X)
- Suvi Tuohinen (ORCID: https://orcid.org/0000-0002-8535-2878)
- Pirkko‐Liisa Kellokumpu‐Lehtinen
- Heidi Lähdeaho
Institutions
- Tampere University of Applied Sciences (FI)
- Helsinki University Hospital (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.ctro.2025.101078
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Suomen Kulttuurirahasto
- Servier